The WW domain of dystrophin requires EF-hands region to interact with β-dystroglycan

Biological Chemistry

Volumn 380, Issue 4, 1999, Pages 431-442

  Rentschler, Stacey ^a   Linn, Hillary ^a   Deininger, Katrin ^a   Bedford, Mark T ^b   Espanel, Xavier ^a   Sudol, Marius ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Modular domains; Muscular dystrophy; Polyprolines; Repertoires of peptides

Indexed keywords

ACTIN; AMINO ACID; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; TRYPTOPHAN; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOSKELETON; EXTRACELLULAR MATRIX; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; SKELETAL MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DNA PRIMERS; DYSTROGLYCANS; DYSTROPHIN; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; PRECIPITIN TESTS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS;

ANIMALIA;

EID: 0032915455     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.057     Document Type: Article

References (63)

1. Bedford, M.T., Chan, D.C., and Leder, P. (1997). FBP WW domains and the AblSH3 domain bind to a specific class of proline-rich ligands. Embo. J. 16, 2376-2383.
2. Bies, R.D., Caskey, C.T., and Fenwick, R. (1992). An intact cysteine-rich domain is required for dystrophin function. J. Clin. Invest. 90, 666-672.
3. Blankenmeyer-Menge, B., Nimtz, M., and Frank, R. (1990). An efficient method for anchoring Fmoc-amino acids to hydroxyl-functionalised solid supports. Tetrahedron 31, 1701-1704.
4. Bork, P., and Sudol, M. (1994). The WW Domain: a signalling site in dystrophin? Trends Biochem. Sci. 19, 531-533.
5. Burghes, A.H., Logan, C., Hu, X., Belfall, B., Worton, R.G., and Ray, P.N. (1987). A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature 325, 434-437.
6. Chan, D.C., Bedford, M.T., and Leder, P. (1996). Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains. EMBO J. 15, 1045-1054.
7. Chen, H.I., and Sudol, M. (1995). The WW Domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for SRC homology 3-binding modules. Proc. Natl. Acad. Sci USA 92, 7819-7823.
8. Chen, H.I., Einbond, A., Kwak, S.J., Linn, H., Koepf, E., Peterson, S., Kelly, J.W., and Sudol, M. (1997). Charaterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J. Biol. Chem. 272, 17070-17077.
9. Cheng, H.-J., and Flanagan, J.G. (1998). Cloning and characterization of RTK ligands using receptor-alkaline phosphatase fusion proteins. In: Protein Kinases, AD Reith, ed. Meth. Mol. Biol., in press.
10. Ciechanover, A. (1994). The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21.
11. Crivici, A., and Ikura, M. (1995). Molecular and structural basis of target recognition by calmoudin. Annu. Rev. Biophys. Biomol. Struc. 24, 85-116.
12. Einbond, A., and Sudol, M. (1996). Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett. 384, 1-8.
13. Ermekova, K.S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., and Sudol, M. (1997). The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophilia enabled. J. Biol. Chem. 272, 32869-32877.
14. Ervasti, J.M., and Campbell, K.P. (1991). Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131.
15. Finn, B.E., Evenas, J., Drakenberg, T., Waltho, J.P., Thulin, E., and Forsen, S. (1995). Calcium-induced structural changes and domain autonomy in calmodulin. Nat. Struct. Biol. 2, 777-783.
16. Frank, R., and Doring, R. (1988). Simultaneous multiple peptide synthesis under continuous flow conditions on cellulose paper discs as segmental solid synthesis. Tetrahedron 44, 6031-6040.
17. Hoffman, E.P., Brown, R.H., Jr., and Kunkel, L.M. (1987). Dystrophin: the protein product of the Duchene muscular dystrophy locus. Cell 51, 919-928.
18. Hyvonen, M., and Saraste, M. (1997) Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinemia. Embo. J. 16, 3396-3404
19. Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W., and Campbell, K.P. (1992). Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702.
20. Ibraghimov-Beskrovnaya, O., Milatovich, A., Ozcelik, T., Yang, B., Koepnick, K., Francke, U., and Campbell, K.P. (1993). Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum. Mol. Genet. 2, 1651-1657.
21. Ikura, M. (1996). Calcium binding and conformational response in EF-hand proteins. Trends Biochem. Sci. 21, 14-17.
22. Ikura, M., Clore, G.M., Gronenborn, A.M., Zhu, G., Klee, C.B., and Bax, A. (1992). Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 256, 632-638.
23. James, P., Vorherr, T., and Carafoli, E. (1995). Calmodulin-binding domains: just two-faced or multi-faceted? Trends Biochem. Sci. 20, 38-42.
24. Jung, D., Yang, B., Meyer, J., Chamberlain, J.S., and Campbell, K.P. (1995). Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J. Biol. Chem. 270, 27305-27310.
25. Kaelin, W.G., Jr., Krek, W., Sellers, W.R., DeCaprio, J.A., Ajchenbaum, F., Fuchs, C.S., Chittenden, T., Li, Y., Farnham, P.J., Blanar, M.A., Livingston, D.M., and Flemington, E.K. (1992). Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364.
26. Koenig, M., Hoffman, E.P., Bertelson, C.J., Monaco, A.P., Feener, C., and Kunkel, L.M. (1987). Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517.
27. Koenig, M., Monaco, A.P., and Kunkel, L.M. (1988). The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219-226.
28. Koenig, M., Beggs, A.H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T. et al. (1989). The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45, 498-506.
29. Kramer, A., Schuster, A., Reineke, U., Malin, R., Volkmer-Engert, R., and Schneider-Mergener, J. (1993). Simultaneous synthesis of peptide libraries on single cellulose membrane supports: examples for the identification of protein, metal and DNA binding peptide mixtures. Peptide Res. 6, 314-319.
30. Kretsinger, R.H., and Nockolds, C.E. (1973). Carp muscle calcium-binding protein. II. Structure determination and general description. J. Biol. Chem. 248, 3313-3326.
31. Kuboniwa, H., Tjandra, N., Grzesiek, S., Ren, H., Klee, C.B., and Bax, A. (1995). Solution structure of calcium-free calmodulin. Nat. Struct. Biol. 2, 768-776.
32. Lenk, U., Oexle, K., Voit, T., Ancker, U., Hellner, K.A., Speer, A., and Hubner, C. (1996). A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave. Hum. Mol. Genet. 5, 973-975.
33. Macias, M.J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., and Oschkinat, H. (1996). Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382, 646-649.
34. Meador, W.E., Means, A.R., and Quiocho, F.A. (1992). Target enzyme recognition by calmodulin. Science 257, 1251-1255.
35. Meador, W.E., Means, A.R., and Quiocho, F.A. (1993). Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. Science 262, 1718-1721.
36. Michalak, M., Fu, S.Y., Milner, R.E., Busaan, J.L., and Hanoe, J.E. (1996) Phosphorylation of the carboxy-terminal region of dystrophin. Biochem. Cell. Biol. 74, 431-437
37. Milner, R.E., Busaan, J., and Michalak, M. (1992). Isolation and characterization of different C-terminal fragments of dystrophin expressed in Escherichia coli. Biochem. J. 288, 1037-1044.
38. Monaco, A.P., Neve, R.L., Colletti-Feener, C., Bertelson, C.J., Kurnit, D.M., and Kunkel, L.M. (1986). Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646-650.
39. Niwa, H., Yamamura, K., and Miyazaki, J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-200.
40. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., and Sweeney, H.L. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
41. Pirozzi, G., McConnell, S.J., Uveges, A.J., Sparks, A.B., Kay, B.K., and Fowlkes, D.M. (1997). Identification of novel human WW domain-containing proteins by cloning of ligand targets. J. Biol. Chem. 272, 14611-14616.
42. Porting, C.P., Blake, D.J., Davies, K.E., Kendrick-Jones, J., and Winder, S.J. (1996). ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem. Sci. 21, 11-13.
43. Rafael, J.A., Cox, G.A., Corrado, K., Jung, D., Campbell, K.P., and Chamberlain, J.S. (1996). Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134, 93-101.
44. Roberts, R.G., Bobrow, M., and Bentley, D.R. (1992). Point mutations in the dystrophin gene. Proc. Natl. Acad. Sci. USA 89, 2331-2335.
45. Rosa, G., Ceccarini, M., Cavaldesi, M., Zini, M., and Petrucci, T.C. (1996) Localization of the dystrophin binding site at the carboxyl terminus of β-dystroglycan. Biochem. and Biophys. Res. Comm. 233, 272-277.
46. Rost, B. and Sander, C. (1993) Prediction of protein structure at better than 70% accuracy. J. Mol. Biol. 232, 584-599.
47. Rost, B., and Sander, C. (1994) Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19, 55-72.
48. Rost, B., Sander, C., and Schneider, R.(1994). PHD-an automatic mail server for protein secondary structure prediction. CABIOS 10, 53-60.
49. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
50. Sudol, M. (1996a). Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 65, 113-132.
51. Sudol, M. (1996b). The WW module competes with the SH3 domain? Trends in Biochem. Sci. 21, 161-163.
52. Sudol, M. (1997). The WW domain and its proline-rich ligand in Alzheimer's disease and muscular dystrophy. Emerging Therapeutic Targets 1, 81-84.
53. Suzuki, A., Yoshida, M., Yamamoto, H., and Ozawa, E. (1992). Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett. 308, 154-160.
54. Suzuki, A., Yoshida, M., Hayashi, K., Mizuno, Y., Hagiwara, Y., and Ozawa, E. (1994). Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur. J. Biochem. 220, 283-292.
55. Tufty, R.M., and Kretsinger, R.H. (1975). Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. Science 187, 167-169.
56. Urbauer, J.L., Short, J.H., Dow, L.K., and Wand, A.J. (1995). Structural analysis of a novel interaction by calmodulin: high-affinity binding of a peptide in the absence of calcium. Biochemistry 34, 8099-8109.
57. Wallace, B.G. (1996) Signaling mechanisms mediating synapse formation. Bioassays 10, 777-780.
58. Winder, S.J. (1997) The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J. Muscle Res. Cell Motil. 18, 617-629.
59. Winder, S.J., Gibson, T.J., and Kendrick-Jones, J. (1995). Dystrophin and utrophin: the missing links! FEBS Lett. 369, 27-33.
60. Yang, B., Jung, D., Motto, D., Meyer, J., Koretzky, G., and Campbell, K.P. (1995) SH3 domain-mediated interaction of dystroglycan and Grb2. J. Biol. Chem. 270, 11711-11714.
61. Yoshida, M., and Ozawa, E. (1990). Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. 108, 748-752.
62. Zhang, O., and Forman-Kay, J.D. (1997) NMR studies of unfolded states of an SH3 domain in aqueous solution and denaturing conditions. Biochemistry 36, 3959-3970.
63. Zhang, M., Tanaka, T., and Ikura, M. (1995). Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat. Struct. Biol. 2, 758-767.